Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men.
about
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistanceAssociation of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects.Adipose tissue gene expression of factors related to lipid processing in obesity.Acylation stimulating protein, complement C3 and lipid metabolism in ketosis-prone diabetic subjects.Diabetes, lipids, and adipocyte secretagogues.Inflammation, thrombosis and acute coronary syndromes.Up-regulation of the complement system in subcutaneous adipocytes from nonobese, hypertriglyceridemic subjects is associated with adipocyte insulin resistancePerformance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body compositionPlasma gamma-glutamyltransferase is strongly determined by acylation stimulating protein levels independent of insulin resistance in patients with acute coronary syndrome.Plasma Levels of Acylation-Stimulating Protein Are Strongly Predicted by Waist/Hip Ratio and Correlate with Decreased LDL Size in Men.Association of immune and metabolic receptors C5aR and C5L2 with adiposity in women.Acylation stimulating protein: a female lipogenic factor?Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes.Complement C3 as a marker of cardiometabolic risk in psoriasis.Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo.The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance.Relationships among acylation-stimulating protein, insulin resistance, lipometabolism, and fetal growth in gestational diabetes mellitus women.Possible role of hyperinsulinemia and insulin resistance in lower vitamin D levels in overweight and obese patientsChange in plasma acylation stimulating protein during euglycaemic-hyperinsulinaemic clamp in overweight and obese postmenopausal women: a MONET study.The molecular mechanism of acylation stimulating protein regulation of adipophilin and perilipin expression: involvement of phosphoinositide 3-kinase and phospholipase C.Hormone and pharmaceutical regulation of ASP production in 3T3-L1 adipocytes.Role of protease inhibitors and acylation stimulating protein in the adipogenesis in 3T3-L1 cells.Weight gain in relation to plasma levels of complement factor 3: results from a population-based cohort study.Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance.Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes.Selenium intake reduces serum C3, an early marker of metabolic syndrome manifestations, in healthy young adults.Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome.Viscerally obese women with normal body weight have greater brachial-ankle pulse wave velocity than nonviscerally obese women with excessive body weight.Increased acylation stimulating protein levels in young obese males is correlated with systemic markers of oxidative stress.Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation.Acylation-stimulating protein: effect of acute exercise and endurance training.
P2860
Q24617743-E04A0326-D07A-4284-BDD1-1EE891C6BC4CQ30384917-F33C4D00-718E-4053-A47C-B3A69D794446Q34037803-D7E7D60D-ED2A-4C80-8E49-A7BC46F9D4E4Q34282344-B82EAA43-D571-496A-9290-993E7DA90C68Q35723496-83DA7E71-2AB7-480A-BCFF-E5A51101DED0Q36333915-C4F59BD0-FE26-47D0-9001-4B62885AB507Q36442478-91089009-5702-4769-A92A-8D015E25E936Q37109805-0E705675-0FBD-4516-93C2-38C852757900Q37176656-613A158E-3FF1-48BF-A887-0B9D2E416E1EQ37515367-4278E9B6-34EF-44A9-83DD-6767B57321EDQ37553814-ED90EBDE-25B9-409D-80AA-3466122B3C7CQ37846807-BCE7951A-A32D-46A2-9E4A-90E88510B297Q38318585-A446E1D2-D10C-4D26-84AA-AED510790377Q39188717-C927F289-7307-40AF-B837-0FC4B4A7CD5EQ40090989-C1D6650D-D0F7-47FC-8641-D3FCE95D820CQ40140325-9B293FC6-9804-4ACB-A920-DF3D43A7B3BEQ40896188-AE8D1183-948D-45FF-90BD-7414BC3384E0Q41833295-BF1F3D7F-32A8-4592-9B51-4253EF18D8F7Q42440246-0313044E-82B6-4619-ABCC-EC29094016C5Q42814308-C768100B-6BA9-49DE-8043-9EF5383399BAQ42830417-8A3AD64D-CB14-4EFF-BDB2-9650B881D4BBQ42834586-667BB2EF-72F8-4CD5-BB94-C309DE446D40Q44015071-5B38F28C-C210-48DF-8B86-D9D0A0050466Q44620944-43C2B6BA-527F-438D-8FF7-BADCD1333301Q44866355-57ECA023-4191-429E-8697-253B6E513667Q46264167-4645DE3A-88E1-463A-B6B6-FEF7CAD5E5C3Q46853706-51B2FEC4-E733-4BE7-B380-26CC3CF6CDE1Q47296501-D022D642-67DD-4593-83EB-0DBBA049AAFEQ50999771-1B734999-E15C-4A88-B5C9-B9FD2CF74883Q51475459-C427AEA0-E3AB-4B52-8CE7-2B22849BD656Q51519198-FCBE22B3-0F75-4643-8CF2-2F816028E83B
P2860
Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Plasma acylation stimulating p ...... betic and type 2 diabetic men.
@ast
Plasma acylation stimulating p ...... betic and type 2 diabetic men.
@en
type
label
Plasma acylation stimulating p ...... betic and type 2 diabetic men.
@ast
Plasma acylation stimulating p ...... betic and type 2 diabetic men.
@en
prefLabel
Plasma acylation stimulating p ...... betic and type 2 diabetic men.
@ast
Plasma acylation stimulating p ...... betic and type 2 diabetic men.
@en
P2093
P356
P1476
Plasma acylation stimulating p ...... betic and type 2 diabetic men.
@en
P2093
E Dusserre
H A Koistinen
S L Karonen
V A Koivisto
P304
P356
10.1161/01.ATV.21.6.1034
P407
P50
P577
2001-06-01T00:00:00Z